SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Shopee Raises Capacity 60% in One Year, Awaits Anvisa Drug-Sales Approval

Shopee says it has increased capacity by 60% in one year and is awaiting Anvisa approval to sell medicines.

SHOPEE

Related stories